Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 62 OF 78 | DISPLAYING 916 - 930 OF 1166 RESULTS

    Jeon Y-J. et al., A set of NF-αºB–regulated microRNAs induces acquired TRAIL resistance in Lung cancer., [Epub ahead of print]., PNAS, Jun 09, 2015

    Cornet E. et. al., Developing Molecular Signatures for Chronic Lymphocytic Leukemia., [Epub ahead of print]., PLoS ONE, Jun 05, 2015

    Bellmunt J. et al., Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors., [Epub ahead of print]., PLoS ONE, Jun 03, 2015

    Holien T. et al., MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy, [Epub ahead of print}., Oncotarget, Jun 02, 2015

    Niu J. et al., Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer., [Epub ahead of print]., Oncogene, Jun 01, 2015

    Patch A-M. et al., Whole–genome characterization of chemoresistant ovarian cancer., [Epub ahead of print]., Nature, May 28, 2015

    Lee H.J. et al., Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes., [Epub ahead of print]., Breast Cancer Res Treat. , May 26, 2015

    Navari M. et. al., The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma , [Epub ahead of print]., Frontiers in Microbiology, May 20, 2015

    Castro N.P. et al., Cripto-1 as a novel therapeutic target for triple negative breast cancer., 20;6(14):11910-29., Oncotarget, May 19, 2015

    Paik P.K. et al., Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping., [Epub ahead of print]., Cancer Discovery, May 13, 2015

    Begg C.B. et al., Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer., [Epub ahead of print]., Cancer Medicine, May 13, 2015

    Park K. et al., Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay., [Epub ahead of print]., Oncotarget, May 12, 2015

    Garcia P.L. et al., The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models., [Epub ahead of print]., Oncogene, May 11, 2015

    Garner J.M. et al., Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline Is Regulated by Different Cancer Stem Cell Populations., [Epub ahead of print]., PLoS ONE, May 08, 2015

    Walter R.F. et al., Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis., [Epub ahead of print]., Oncotarget, May 04, 2015